Vanguard Group Inc
- SEC CIK
- 0000102909
- Latest filing
- Jan 29, 2026
KTTA holding history
Pasithea Therapeutics Corp. in every 13F filed by Vanguard Group Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KTTA overviewAll 13F holders of KTTAFull Q4 2025 holdings
- Shares (Q4 2025)
- 97,675
- Value
- $126.0K
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 97,675 | $126.0K | <0.1% | +43,860+81.5% | Added | Holders |
| Q3 2025 | 53,815 | $38.7K | <0.1% | +53,815 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −121,007−100.0% | Sold out | Holders |
| Q2 2023 | 121,007 | $59.3K | <0.1% | −39,188−24.5% | Reduced | Holders |
| Q1 2023 | 160,195 | $60.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 160,195 | $102.8K | <0.1% | +351+0.2% | Added | Holders |
| Q3 2022 | 159,844 | $201.0K | <0.1% | +81,705+104.6% | Added | Holders |
| Q2 2022 | 78,139 | $79.0K | <0.1% | +21,556+38.1% | Added | Holders |
| Q1 2022 | 56,583 | $74.0K | <0.1% | +43,883+345.5% | Added | Holders |
| Q4 2021 | 12,700 | $22.0K | <0.1% | +12,700 | New | Holders |